The global Immuno-Oncology Drugs Market is evolving as pharmaceutical and biotechnology companies strengthen their focus on immune-based cancer treatments. The market includes checkpoint inhibitors, monoclonal antibodies, cancer vaccines, cytokine therapies, and cellular immunotherapies. Increasing cancer prevalence, growing research and development expenditure, and advances in treatment design...